First data on effects and pharmacokinetics of isosorbide-5-mononitrate in normal man

[1]  B. Kaufmann,et al.  Effects and pharmacokinetics of isosorbide dinitrate in normal man , 1980, European Journal of Clinical Pharmacology.

[2]  W. Bussmann,et al.  [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)]. , 1981, Die Medizinische Welt.

[3]  V. F. Smolen.  Bioavailability and pharmacokinetic analysis of drug responding systems. , 1978, Annual review of pharmacology and toxicology.

[4]  M. Bogaert,et al.  GLC determination of nitroglycerin and isosorbide dinitrate in human plasma. , 1973, Journal of pharmaceutical sciences.

[5]  L. Endrenyi,et al.  Effect of chlorthalidone on blood vessels. , 1972, The Journal of pharmacology and experimental therapeutics.

[6]  R. Wendt.  Systemic and coronary vascular effects of the 2- and the 5-mononitrate esters of isosorbide. , 1972, The Journal of pharmacology and experimental therapeutics.

[7]  R. De,et al.  Identification of the urinary metabolites of isosorbide dinitrate in dogs. , 1971 .

[8]  S. Sisenwine,et al.  Plasma concentrations and urinary excretion of isosorbide dinitrate and its metabolites in the dog. , 1971, The Journal of pharmacology and experimental therapeutics.

[9]  L. Hart,et al.  Identification of the urinary metabolites of isosorbide dinitrate in dogs. , 1971, Archives internationales de pharmacodynamie et de therapie.

[10]  B. Lüderitz,et al.  Regulationsprüfung des Kreislaufs , 1954 .